FDA issued a Warning Letter to Sovereign Pharmaceuticals, LLC on 01/29/2013 for a previous inspection.
483 Sovereign Pharmaceuticals Apr 2022

483 Sovereign Pharmaceuticals Apr 2022

Patty Kaewussdangkul FDA, Adaris Mas Rivera FDA, Martrice Packer FDA$119.00 - Available Now

FDA investigators audited the Sovereign Pharmaceuticals - Fort Worth, TX, United States facility and issued inspectional observations (via FDA 483) on 22 Apr 2022.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Apr 2022
  • Location: Fort Worth, United States
  • FEI: 3003229412
Add To Cart